Novel inactivating mutations in the FSH receptor cause premature ovarian insufficiency with resistant ovary syndrome |
| |
Authors: | Wen-Bin He Juan Du Xiao-Wen Yang Wen Li Wei-Lin Tang Can Dai Yong-Zhe Chen Ya-Xin Zhang Guang-Xiu Lu Ge Lin Fei Gong Yue-Qiu Tan |
| |
Affiliation: | 1. Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan 410078, People’s Republic of China;2. Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan 410078, People’s Republic of China;3. NHC Key Laboratory of human stem cell and reproductive engineering, Changsha, Hunan 410078, People’s Republic of China;4. School of Medicine, Hunan Normal University, Changsha, Hunan 410013, People’s Republic of China |
| |
Abstract: | Research questionWhat is the genetic aetiology of three resistant ovary syndrome (ROS) pedigrees from 13 Chinese Han families with non-syndromic premature ovarian insufficiency (POI).DesignThe proband in each family was subjected to whole-exome sequencing. Bioinformatic and in-vitro functional analyses were performed for the functional characterization of the FSHR mutations.ResultsFour novel mutations, two homozygous mutations (c.419delA, c.1510C>T), and a compound heterozygous mutation (c.44G>A and deletion of exons 1 and 2) of FSHR were identified in the three non-syndromic POI-with-ROS families. Bioinformatic analysis predicted that the three novel point mutations in FSHR are deleterious and associated with POI in the three families, which was confirmed by in-vitro functional analysis, in which FSH-induced adenosine 3′,5′-cyclic monophosphate production was abolished for all receptors.ConclusionsThe three novel point mutations in FSHR were all functional inactivating mutations, and were the genetic aetiology of the three non-syndromic POI-with-ROS families. The first FSHR frameshift mutation is reported here, and the first missense mutation in the signal peptide-encoding region of FSHR to be associated with POI. Women affected by ROS should consider undergoing mutation screening for FSHR. |
| |
Keywords: | FSHR gene Frameshift mutation Novel mutation Premature ovarian insufficiency Resistant ovary syndrome |
本文献已被 ScienceDirect 等数据库收录! |
|